Nifty
Sensex
:
:
11709.80
39931.66
-179.60 (-1.51%)
-590.44 (-1.46%)

Pharmaceuticals & Drugs

Rating :
76/99  (View)

BSE: 531637 | NSE: Not Listed

49.20
-1.00 (-1.99%)
28-Oct-2020 | 1:15PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  49.20
  •  49.20
  •  49.20
  •  50.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  757
  •  0.37
  •  80.80
  •  4.07

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 92.79
  • 18.80
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 91.61
  • 2.99%
  • 6.20

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 73.97%
  • 2.07%
  • 23.22%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 0.74%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 30.64
  • -
  • 1156.55

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 73.73
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 28.16

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 20.72

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
2
0
0
23
0
0
0
0
0
0
0
0
Expenses
2
0
0
16
0
0
0
0
0
0
0
0
EBITDA
0
0
0
7
0
0
0
0
0
0
0
0
EBIDTM
18%
0%
29%
0%
0%
0%
0%
0%
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0
0
0
6
0
0
0
0
0
0
0
0
Tax
0
0
0
2
0
0
0
0
0
0
0
0
PAT
0
0
0
5
0
0
0
0
0
0
0
0
PATM
4%
0%
20%
0%
0%
0%
0%
0%
EPS
0.05
0.00
0
2.52
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 20
Mar 19
Net Sales
-
60
60
Net Sales Growth
-
-1%
 
Cost Of Goods Sold
-
27
33
Gross Profit
-
33
27
GP Margin
-
55%
45%
Total Expenditure
-
53
56
Power & Fuel Cost
-
1
0
% Of Sales
-
2%
1%
Employee Cost
-
4
3
% Of Sales
-
7%
5%
Manufacturing Exp.
-
14
12
% Of Sales
-
24%
19%
General & Admin Exp.
-
4
6
% Of Sales
-
7%
10%
Selling & Distn. Exp.
-
2
2
% Of Sales
-
3%
3%
Miscellaneous Exp.
-
1
0
% Of Sales
-
1%
0%
EBITDA
-
6
4
EBITDA Margin
-
11%
7%
Other Income
-
0
1
Interest
-
1
0
Depreciation
-
1
0
PBT
-
5
4
Tax
-
2
1
Tax Rate
-
30%
29%
PAT
-
4
3
PAT before Minority Interest
-
4
3
Minority Interest
-
0
0
PAT Margin
-
6%
5%
PAT Growth
-
28%
 
EPS
-
1.97
1.54

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Shareholder's Funds
15
12
Share Capital
18
5
Total Reserves
-4
-7
Non-Current Liabilities
1
1
Secured Loans
1
1
Unsecured Loans
0
0
Long Term Provisions
0
0
Current Liabilities
9
9
Trade Payables
5
4
Other Current Liabilities
3
2
Short Term Borrowings
0
3
Short Term Provisions
1
1
Total Liabilities
25
21
Net Block
3
3
Gross Block
6
5
Accumulated Depreciation
3
2
Non Current Assets
3
3
Capital Work in Progress
0
0
Non Current Investment
0
0
Long Term Loans & Adv.
0
0
Other Non Current Assets
0
0
Current Assets
21
18
Current Investments
0
0
Inventories
2
2
Sundry Debtors
14
13
Cash & Bank
3
2
Other Current Assets
2
1
Short Term Loans & Adv.
1
1
Net Current Assets
12
10
Total Assets
25
21

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Cash From Operating Activity
6
3
PBT
5
4
Adjustment
1
4
Changes in Working Capital
1
-4
Cash after chg. in Working capital
7
4
Interest Paid
0
0
Tax Paid
-1
-2
Other Direct Exp. Paid
0
0
Extra & Other Items
0
0
Cash From Investing Activity
-1
-3
Net Fixed Assets
-1
Net Investments
0
Others
1
Cash from Financing Activity
-3
0
Net Cash Inflow / Outflow
2
0
Opening Cash & Equivalents
1
0
Closing Cash & Equivalent
3
1

Financial Ratios

Standalone /

Consolidated
Description
Mar 20
Mar 19
Book Value (Rs.)
8
-3
ROA
16%
13%
ROE
55%
0%
ROCE
36%
28%
Fixed Asset Turnover
11.02
12.61
Receivable days
83
79
Inventory Days
13
12
Payable days
34
29
Cash Conversion Cycle
63
62
Total Debt/Equity
0.13
-2.42
Interest Cover
11
11

News Update


  • Praveg Communications to resume operations at Kevadia site
    29th Aug 2020, 10:11 AM

    The company is planning to resume operations with effect from September 1, 2020

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.